Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China
· Delayed Price · Currency is CNY 17.41
-0.06 (-0.34%)
Apr 30, 2026, 9:55 AM CST
SHA:603896 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,463 | 3,842 | 4,205 | 6,391 | 7,821 | 8,835 | Upgrade
|
| Market Cap Growth | -15.15% | -8.63% | -34.21% | -18.28% | -11.47% | 75.22% | Upgrade
|
| Enterprise Value | 2,945 | 3,336 | 3,633 | 5,674 | 7,115 | 8,199 | Upgrade
|
| Last Close Price | 17.47 | 19.38 | 20.96 | 31.35 | 38.17 | 42.59 | Upgrade
|
| PE Ratio | 194.11 | 211.40 | 24.07 | 25.12 | 28.16 | 43.99 | Upgrade
|
| Forward PE | - | 22.02 | 13.91 | 20.94 | 23.38 | 39.93 | Upgrade
|
| PS Ratio | 5.41 | 6.00 | 6.08 | 8.15 | 9.43 | 11.52 | Upgrade
|
| PB Ratio | 1.53 | 1.70 | 1.83 | 2.94 | 4.10 | 5.45 | Upgrade
|
| P/TBV Ratio | 1.82 | 2.02 | 2.17 | 3.44 | 4.28 | 5.75 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 49.29 | 65.41 | Upgrade
|
| P/OCF Ratio | 15.19 | 16.85 | 19.70 | 20.29 | 22.92 | 29.78 | Upgrade
|
| EV/Sales Ratio | 4.60 | 5.21 | 5.25 | 7.23 | 8.58 | 10.69 | Upgrade
|
| EV/EBITDA Ratio | 13.74 | 16.52 | 19.54 | 21.20 | 24.06 | 35.12 | Upgrade
|
| EV/EBIT Ratio | 23.77 | 26.93 | 29.91 | 28.22 | 29.84 | 44.49 | Upgrade
|
| EV/FCF Ratio | -65.23 | - | - | - | 44.84 | 60.70 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.26 | 0.35 | 0.37 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 2.87 | 2.87 | 2.98 | 2.70 | 2.33 | 0.45 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 4.45 | 0.79 | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.27 | -0.35 | -0.44 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.57 | -2.57 | -3.29 | -2.82 | -2.87 | -3.00 | Upgrade
|
| Net Debt / FCF Ratio | 11.51 | 11.51 | 2.08 | 7.60 | -5.35 | -5.19 | Upgrade
|
| Asset Turnover | 0.20 | 0.20 | 0.22 | 0.26 | 0.34 | 0.42 | Upgrade
|
| Inventory Turnover | 0.70 | 0.70 | 0.79 | 0.89 | 1.05 | 1.27 | Upgrade
|
| Quick Ratio | 2.26 | 2.26 | 3.38 | 2.77 | 3.55 | 4.66 | Upgrade
|
| Current Ratio | 2.69 | 2.69 | 3.90 | 3.09 | 3.90 | 5.25 | Upgrade
|
| Return on Equity (ROE) | 0.80% | 0.80% | 7.83% | 12.48% | 15.74% | 13.60% | Upgrade
|
| Return on Assets (ROA) | 2.42% | 2.42% | 2.41% | 4.17% | 6.19% | 6.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.24% | 1.28% | 7.84% | 16.24% | 24.10% | 21.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.50% | 4.50% | 4.40% | 7.80% | 10.00% | 10.50% | Upgrade
|
| Earnings Yield | 0.52% | 0.47% | 4.15% | 3.98% | 3.55% | 2.27% | Upgrade
|
| FCF Yield | -1.30% | -1.18% | -6.98% | -1.56% | 2.03% | 1.53% | Upgrade
|
| Dividend Yield | 1.48% | - | 1.29% | 1.24% | 1.15% | 0.73% | Upgrade
|
| Payout Ratio | 327.37% | 327.37% | 47.51% | 36.46% | 22.00% | 23.66% | Upgrade
|
| Buyback Yield / Dilution | -1.87% | -1.71% | -1.42% | -0.77% | -1.56% | -3.77% | Upgrade
|
| Total Shareholder Return | -0.41% | -1.71% | -0.14% | 0.47% | -0.41% | -3.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.